Abstract:Background: Coumarin and 3,4-dihydroquinolinone nuclei are two heterocyclic rings that are important and widely exploited for the development of bioactive molecules. Here, we designed and synthesized a series of 3,4-dihydroquinolinone and coumarin derivatives (Compounds 8,9,11,14,15,18-20, 23, 24 and 28 are new compounds) and studied their antidepressant activities. Methods: Forced swimming test (FST) and tail suspension test (TST) were used to evaluate the antidepressant activity of the target compounds. The most active compound was used to evaluate the exploratory activity of the animals by the open-field test. 5-HT concentration was estimated to evaluate if the compound has an effect on the mouse brain, by using ELISA. A 5-HT1A binding assay was also performed. The biological activities of the compounds were verified by molecular docking studies. The physicochemical and pharmacokinetic properties of the target compounds were predicted by Discovery Studio and ChemBioDraw Ultra. Results: Of all the compounds tested, compound 7 showed the best antidepressant activity, which decreased the immobility time by 65.52 s in FST. However, in the open-field test, compound 7 did not affect spontaneous activity. The results of 5-HT concentration estimation in vivo showed that compound 7 may have an effect on the mouse brain. Molecular docking results indicated that compound 7 showed significant interactions with residues at the 5-HT1A receptor using homology modeling. The results show that compound 7 exhibits good affinity for the 5-HT1A receptor. Conclusion: Coumarin and 3,4-dihydroquinolinone derivatives synthesized in this study have a significant antidepressant activity. These findings can be useful in the design and synthesis of novel antidepressants.

Synthesis of ring-opened derivatives of triazole-containing quinolinones and their antidepressant and anticonvulsant activities

Design, synthesis and evaluation of the antidepressant and anticonvulsant activities of triazole-containing quinolinones.

Synthesis and Studies on Anticonvulsant and Antidepressant Activities of 5-Alkoxy-tetrazolo[1,5-a]quinolines

Synthesis and Neuroprotective Biological Evaluation of Quinazolinone Derivatives Via Scaffold Hopping.

Synthesis and Antidepressant Activities of 4-(Substituted-phenyl)tetrazolo[1,5-a]quinazolin-5(4h)-ones and Their Derivatives

Synthesis and Evaluation on Anticonvulsant and Antidepressant Activities of 5‐Alkoxy‐tetrazolo[1,5‐a]quinazolines

Synthesis and Anticonsulvant Activity of 1,2,4-Triazolo[4,3-a] Quinolines

Synthesis and Evaluation of the Antidepressant Activity of Quinoxaline-2,3(1H,4H)-dione Derivatives

Coumarin and 3,4-Dihydroquinolinone Derivatives: Synthesis, Antidepressant Activity, and Molecular Docking Studies.

Synthesis and anticonvulsant activity of 7-benzylamino-4, 5dihydro-[1,2,4] triazolo[4,3-a]quinolines

Synthesis and Anticonvulsant Activity Evaluation of 4-Phenyl-[1,2,4]triazolo[4,3-a]quinazolin-5(4h)-one and Its Derivatives

Synthesis of 2-Substituted-7-heptyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolin-1(2 H)-Ones with Anticonvulsant Activity

Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.

Synthesis and anticonvulsant activity of 1-substituted-7-benzyloxy-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinoline.

The Synthesis and Anticonvulsant Activity of 1-Substituted-7-methoxy-1,2,4-triazolo [4, 3-A] Quinoline

Synthesis and Anticonvulsant Activity of 7-Alkoxyl-4,5-dihydro-[1,2,4]triazolo[4,3-a]quinolines

Synthesis and Anticonvulsant Activity of 5-Substituted-[1,2,4]triazolo[4,3-a]quinazolines

Synthesis and biological evaluation of a series of benzoxazole/benzothiazole-containing 2,3-dihydrobenzo[b][1,4]dioxine derivatives as potential antidepressants.

Synthesis of Some Quinoline-2(1H)-one and 1, 2, 4 - Triazolo [ 4 , 3 -a ] Quinoline Derivatives As Potent Anticonvulsants.

Synthesis and Anticonvulsant Activity of 1-Formamide-triazolo[4,3a]quinoline Derivatives

Synthesis and evaluation of novel 2,3-dihydrobenzo[b][1,4]dioxin- and indolealkylamine derivatives as potential antidepressants.